COVID-19 Resources Hub
We are highlighting open access, peer-reviewed content with relevance to resource-variable settings. Please check back as we are making new content and adding new resources soon. Please send suggestions and check out our full Resource Library.
Results:
Recently added
Check out our OCC Image Library for more free clinical education images. Available to download in high resolution .png or .ai file types.
This brochure is intended to help clinicians at the point of care initiate oral antiviral treatment for COVID-19. Please check the latest published data prior to using this brochure.
This tool was created by USAID Implementing partners EpIC and STAR-UCSF.
This brochure is intended to help clinicians at the point of care initiate oral antiviral treatment for COVID-19. Please check the latest published data prior to using this brochure.
This tool was created by USAID Implementing partners EpIC and STAR-UCSF.
Check out our OCC Image Library for more free clinical education images. Available to download in high resolution .png or .ai file types.
Check out our OCC Image Library for more free clinical education images. Available to download in high resolution .png or .ai file types.
Développer des compétences cliniques pour le Tester-pour-traiter, y compris l'identification des patients suspects de COVID-19, le triage, l'IPC, les tests de diagnostic rapide et les options de gestion/traitement. Ce programme a été développé par FHI 360 avec le soutien de l'USAID. Le cours est accessible au public gratuitement sur la plateforme EpiC Learns LMS (www.academy.fhi360.org/epic) en francés.
Desarrolle habilidades clínicas para Prueba-para-Tratar, incluida la identificación de pacientes con sospecha de COVID-19, triaje, prevención y control de infecciones (PCI), pruebas de diagnóstico rápido y opciones de atención/tratamiento. Este currículo fue desarrollado por FHI 360 con el apoyo de USAID. El curso está disponible al público de forma gratuita en la plataforma EpiC Learns LMS (www.academy.fhi360.org/epic) en español.
Développer des compétences cliniques pour le Tester-pour-traiter, y compris l'identification des patients suspects de COVID-19, le triage, l'IPC, les tests de diagnostic rapide et les options de gestion/traitement. Ce programme a été développé par FHI 360 avec le soutien de l'USAID. Le cours est accessible au public gratuitement sur la plateforme EpiC Learns LMS (www.academy.fhi360.org/epic) en francés.
Test-to-Treat for COVID-19 is an online, self-paced learning module to build clinical skills for T2T, including identification of patients with suspected COVID-19, triage, IPC, rapid diagnostic testing and management/treatment options. The target audience is frontline healthcare workers who may encounter patients with symptoms consistent with possible COVID-19. The course is available to the public for free on the EpiC Learns LMS platform (www.academy.fhi360.org/epic) in English.
This PDSA Tool (Plan, Do, Study, Act) was created by RISE to aid in the implementation of Test-to-Treat programs, and serves as a template for other locations undergoing similar activities.
This FAQ provides answers to frequently asked questions about the COVID-19 Test to Treat strategy for clinicians, prescribers and health care teams.
This document provides answers to frequently asked questions about the COVID-19 Test to Treat strategy for clinicians, prescribers and health care teams.
An interactive version of the latest FAQ is also available via the link below.
Information for clinicians on mechanism of action for Molnupiravir, contraindications & indications, general dosage guidelines
Information for clinicians on mechanism of action for Paxlovid, contraindications & indications, general dosage guidelines.
Brief overview of the Test-to-Treat activity, answers key questions on purpose and target population
Information on purpose and use of self-tests in various environments.
Check out our OCC Job Aid Builder Tool for more free content to make your own job aid. Topics include respiratory care, emergency algorithms, critical care medications, procedures with more topics and more languages coming soon.
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
Two-page information sheet designed for patients who are taking molnupiravir. It is intended to be printed double-sided and folded in half.